Business Context and Reporting Period
Accuray Incorporated filed this Form 8-K on April 3, 2007, to disclose the entry into a Material Definitive Agreement. The company is a Delaware corporation headquartered in Sunnyvale, California.
Key Financial Metrics
This filing does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on a strategic partnership agreement.
Material Changes
On April 3, 2007, Accuray entered into a Distribution and Remarketing Agreement with Siemens Medical Solutions Inc. USA (Oncology Care Systems Group or "OCS"). Key terms include:
- Authorization: Accuray is authorized to purchase, license, sell, and sublicense certain OCS products.
- Products: The agreement covers specific models of CT scanners.
- Scope: Accuray may promote, market, lease, resell, and sublicense these scanners in the U.S. and other territories, either directly or through distribution channels.
- Integration: The CT scanners are to be marketed in conjunction with Accuray's CyberKnife and RoboCouch products.
- Term: The agreement is valid for three years unless terminated earlier.
Guidance, Outlook, and Risks
The filing does not contain financial guidance, management commentary on future performance, or specific risk factors related to the agreement. The company intends to seek confidential treatment for the specific financial terms of the agreement, which will be filed as an exhibit to its Annual Report on Form 10-K for the year ended June 30, 2007.
Investor Verification Checklist
- Verify the specific financial terms of the agreement once filed in the Form 10-K for the year ended June 30, 2007.
- Confirm the exact models of CT scanners covered under the distribution rights.
- Monitor future filings for any updates on the commercialization of the integrated CyberKnife/CT scanner solutions.